Feedback / Questions
sozinibercept (OPT-302) - Opthea
https://www.globenewswire.com/news-release/2024/02/14/2828968/0/en/Opthea-Completes-Enrollment-in-First-Pivotal-Trial-with-Sozinibercept.html
Feb 14, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next